Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

One-year survival and recovery in elderly COVID-19 patients under scrutiny

NCT ID NCT05184166

Knowledge-focused Sponsor: Centre Hospitalier le Mans Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study follows people aged 70 and older who were hospitalized with severe COVID-19 for one year after their diagnosis. Researchers aim to describe how many survive and how well they recover, including physical and mental function. The goal is to better understand the long-term impact of severe COVID-19 in older adults.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better predict recovery and plan care for older patients with severe COVID-19.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove what helps or harms. Results may not apply to all elderly patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

361 people

The number who actually took part.

Started

Mar 2022

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged 70 years and over with severe COVID-19

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age ≥ 70 years on admission to hospital * diagnosis of SARS-CoV-2 infection defined by a positive RT-PCR test * medical or critical care hospitalisation between 1 July 2020 and 31 August 2021 * who experienced severe hypoxaemic acute respiratory failure defined as at least 4L/min of oxygen during hospitalisation Exclusion Criteria: * Oxygen therapy \< 4L/min during hospitalisation * Mc Cabe score 3 (chronic disease fatal at 1 year such as stage IV heart failure, ventilated respiratory failure, metastatic cancer, Child C cirrhosis) * dementia or cognitive disorders before hospitalisation reported in the medical record * patient GIR 1 to 4 before hospitalisation reported in the medical file or deduced from the description of the lifestyle * patient with an ADL score \< 4 before hospitalisation reported in the medical record or deduced from the description of lifestyle * patient living in EHPAD before hospitalisation * non-French speaking patient * patient under guardianship or curatorship * refusal to participate in the study for patients surviving 1 year or refusal by a family member or trusted person

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID -19 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID -19 Elderly patient

Contacts and locations

Locations

  • Centre Hospitalier Du Mans

    Le Mans, 72000, France

  • Chu Angers

    Angers, 49000, France

  • Chu Rennes

    Rennes, 35000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.